Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-18

FDA Approved: ENTECAVIR — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for ENTECAVIR from Aurobindo Pharma Limited under the ANDA, enabling continued marketing of the generic antiviral for he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

SUPPL AP for ENTECAVIR (ENTECAVIR)